LAKE SUCCESS, N.Y., Oct. 28, 2016 /PRNewswire-USNewswire/ -- IPRO has been awarded special federal funding to promote the use of a medication management tool it recently converted from a paper-based format to a mobile application. The free, smart phone application and online tool developed by an IPRO-led coalition enables clinicians to easily determine whether, when, and how to stop and restart the use of warfarin and oral anticoagulants during elective surgery and other invasive procedures.
Intuitively organized, the Management of Anticoagulation in the Peri-Procedural Period, or MAPPP app, provides individualized patient guidance for management of anticoagulant medications based on patient thrombosis (blood clot) risk and specific procedural bleeding risk. The tool is currently available on the Apple App Store and on Google Play for Androids.
Under a new, two-year award from the Centers for Medicare & Medicaid Services (CMS), IPRO and its Atlantic Quality Innovation Network (AQIN) will educate physicians and provider staff on the MAPPP app, promote its integration into clinical decision support (CDS) at selected healthcare systems and develop a process for incorporating the app into electronic health record CDS across multiple inpatient and outpatient vendor systems.
"While the medical literature contains expert guidance for the use of anticoagulants during invasive procedures, to our knowledge there has never been a simplified reference guide to anticoagulant use that clinicians can quickly refer to when planning these procedures," said Clare B. Bradley MD, MPH, IPRO's Senior Vice President and Chief Medical Officer. "Our task force saw this need, and developed this useful tool."
CMS made the MAPPP tool funding announcement as one of twenty, 2-year Special Innovation Projects awarded to 12 Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs). The IPRO-led AQIN QIO is funded by Medicare to work with healthcare providers in New York, South Carolina and the District of Columbia.
In announcing the twenty special awards on the Agency's blog, CMS Chief Medical Officer Patrick Conway, MD, MSc and colleagues hailed the projects as creating "an exciting opportunity for providers, professional organizations, innovation labs, and others to innovate and impact health care quality in the Medicare program at local, regional and national levels through the QIO Program."
A nationally recognized not-for-profit currently operating in 33 states and territories, IPRO offers a wide range of services including quality improvement and assessment activities; utilization review; independent review of patient appeals; data collection, analysis and validation; anti-fraud and abuse analytics and online performance reporting for government agencies, managed care organizations and private sector clients. In addition, IPRO operates the WhyNotTheBest website, a comprehensive quality improvement resource that analyzes the performance of 5,686 acute care hospitals in the U.S.
An ISO certified organization, IPRO is headquartered in Lake Success, NY, with offices in Albany NY, as well as Connecticut, New Jersey, Pennsylvania, North Carolina, Ohio and California. For more information about IPRO, please visit www.ipro.org.
This material was prepared by the Atlantic Quality Innovation Network (AQIN), the Medicare Quality Innovation Network-Quality Improvement Organization for New York State, South Carolina, and the District of Columbia, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents do not necessarily reflect CMS policy. 11SOW-AQINNY-TskSIP-MAPP-16-01
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ipro-wins-special-funding-to-promote-medication-management-tool-300352937.html